-
Mashup Score: 2The geneticist who uses science to free parents wrongly convicted of killing their children - 7 day(s) ago
Nature – Carola Vinuesa describes how her career changed after identifying a genetic mutation that helped to secure the freedom of Kathleen Folbigg, who was serving a 30-year jail term for killing…
Source: www.nature.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 0
Nature – Technological advances can reduce the numbers of laboratory animals used in studies — but they need to be carefully validated.
Source: www.nature.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 28woMMen trekking Peru - 13 day(s) ago
As women myeloma physicians, we walk beside our patients as they face their mountains. Now, we’re facing mountains of our own as we trek almost 30 miles through the Ausangate mountain in the Andes with an altitude of up to 16,900 feet in Peru in July 2024!Why?Because hard things are worth doing.B…
Source: give.healthtree.orgCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 28woMMen trekking Peru - 16 day(s) ago
As women myeloma physicians, we walk beside our patients as they face their mountains. Now, we’re facing mountains of our own as we trek almost 30 miles through the Ausangate mountain in the Andes with an altitude of up to 16,900 feet in Peru in July 2024!Why?Because hard things are worth doing.B…
Source: give.healthtree.orgCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 44
Dr. Urvi Shah and several other women physicians are hiking in Peru in order to raise funds for myeloma research. Learn more and donate today!
Source: healthtree.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 28woMMen trekking Peru - 17 day(s) ago
As women myeloma physicians, we walk beside our patients as they face their mountains. Now, we’re facing mountains of our own as we trek almost 30 miles through the Ausangate mountain in the Andes with an altitude of up to 16,900 feet in Peru in July 2024!Why?Because hard things are worth doing.B…
Source: give.healthtree.orgCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 28
PURPOSE To compare effects and side effects of 6 weeks of individually dose-titrated methylphenidate or placebo on fatigue in palliative care patients with advanced cancer. METHODS This is a randomized, double-blind, placebo-controlled, multicenter trial. Eligible patients had advanced incurable cancer and fatigue >3/10. Principal exclusions were hypertension; psychiatric, cardiovascular, cerebrovascular, renal, liver, or blood disorders; substance dependency; and epilepsy. Patients were randomly assigned 1:1 methylphenidate or placebo starting at 5 mg twice daily. Dose of methylphenidate/placebo was titrated once per week, over 6 weeks, up to a maximum of 20 mg three times daily. Trial ended at 10 weeks. Primary outcome was the difference in Functional Assessment of Chronic Illness Therapy Fatigue (FACIT-F) scores between groups at 6 ± 2 weeks. Secondary outcomes included adverse effects, quality of life, and mood. RESULTS One hundred sixty-two patients (73 men; mean, 65.8; standard d
Source: ascopubs.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 45
This randomized clinical trial assesses whether sensorimotor training and whole-body vibration training reduce symptoms and decrease the onset of chemotherapy-induced peripheral neuropathy.
Source: jamanetwork.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 5REAL-WORLD SCHEDULE DE-ESCALATION OF TECLISTAMAB IN PATIENTS WITH RRMM | Carlyn Tan, MD | EHA 2024 - 22 day(s) ago
Recorded on 06/25/24 as part of the EHA 2024 Coverage by HealthTree Foundation.The HealthTree Foundation for Multiple Myeloma brings information from the exp…
Source: www.youtube.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 16Mortality in the US Populations With MGUS - 23 day(s) ago
This cohort study analyzes a nationally representative sample with a screening test for monoclonal gammopathy of undetermined significance (MGUS) to evaluate overall survival of populations with MGUS compared with those without MGUS among the general population in the US.
Source: jamanetwork.comCategories: General Medicine News, Oncologists1Tweet
The geneticist who uses science to free parents wrongly convicted of killing their children @NaturePortfolio https://t.co/8ipwqeFtJo